ANTICYTOPLASMIC ANTIBODY - ANVISA Registration 10225960028

Access comprehensive regulatory information for ANTICYTOPLASMIC ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10225960028 and manufactured by SCIMEDX CORPORATION. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10225960028
Registration Details
ANVISA Registration Number: 10225960028
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ANCA IMUNOFLUORESCENCIA
Risk Class II

Registration Details

10225960028

253510066720124

68814961000173

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Aug 09, 2001

VIGENTE

09/18/2025 19:00:01